{"id":"https://openalex.org/W2403549100","doi":null,"title":"Epidermal growth factor receptor inhibitors for the treatment of colorectal cancer: a promise fulfilled?","display_name":"Epidermal growth factor receptor inhibitors for the treatment of colorectal cancer: a promise fulfilled?","publication_year":2004,"publication_date":"2004-04-01","ids":{"openalex":"https://openalex.org/W2403549100","mag":"2403549100","pmid":"https://pubmed.ncbi.nlm.nih.gov/15134356"},"language":"en","primary_location":{"id":"pmid:15134356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15134356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013636222","display_name":"Nevena Damjanov","orcid":"https://orcid.org/0000-0002-4195-7277","observed_orcids":["https://orcid.org/0000-0002-4195-7277"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nevena Damjanov","raw_affiliation_strings":["Temple University, Fox Chase-Temple Cancer Center, Philadelphia, Pennsylvania 19140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Temple University, Fox Chase-Temple Cancer Center, Philadelphia, Pennsylvania 19140, USA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I84392919"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053128814","display_name":"Neal J. Meropol","orcid":"https://orcid.org/0000-0001-6353-7364","observed_orcids":["https://orcid.org/0000-0001-6353-7364"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal J Meropol","raw_affiliation_strings":["Fox Chase Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center,","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0998,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.76438698,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"18","issue":"4","first_page":"479","last_page":"88; discussion 488, 493, 497 passim"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.025499999523162842,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9909999966621399},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7459999918937683},{"id":"https://openalex.org/keywords/clinical-drug-development","display_name":"clinical development","score":0.6330000162124634},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6399999856948853},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.815506100654602},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7731133699417114},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7059511542320251},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.5843851566314697},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.5593704581260681},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5356423854827881},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5335721373558044},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4912073016166687},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.4810529053211212},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40924155712127686},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4016430974006653},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3413693308830261}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:15134356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15134356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1501383613","https://openalex.org/W1526030166","https://openalex.org/W1548966243","https://openalex.org/W1565510860","https://openalex.org/W1569865130","https://openalex.org/W1599518523","https://openalex.org/W1659692600","https://openalex.org/W1665534178","https://openalex.org/W1779286308","https://openalex.org/W1931708823","https://openalex.org/W1939364580","https://openalex.org/W1979224484","https://openalex.org/W1998599114","https://openalex.org/W2007030561","https://openalex.org/W2008803651","https://openalex.org/W2011642803","https://openalex.org/W2028415754","https://openalex.org/W2038882649","https://openalex.org/W2056681493","https://openalex.org/W2062468721","https://openalex.org/W2067376187","https://openalex.org/W2071551577","https://openalex.org/W2085141824","https://openalex.org/W2095483608","https://openalex.org/W2098487639","https://openalex.org/W2108024566","https://openalex.org/W2110544196","https://openalex.org/W2114291028","https://openalex.org/W2123413031","https://openalex.org/W2126314379","https://openalex.org/W2130461015","https://openalex.org/W2134166159","https://openalex.org/W2140252749","https://openalex.org/W2143508222","https://openalex.org/W2155977433","https://openalex.org/W2170517479","https://openalex.org/W2171128277","https://openalex.org/W2255384265","https://openalex.org/W2291334052","https://openalex.org/W2337262864","https://openalex.org/W2405262285","https://openalex.org/W2408833215","https://openalex.org/W2731594918"],"related_works":["https://openalex.org/W2096467824","https://openalex.org/W2027230571","https://openalex.org/W62399000","https://openalex.org/W2011104583","https://openalex.org/W63726329","https://openalex.org/W2946423290","https://openalex.org/W2416584807","https://openalex.org/W2066715163","https://openalex.org/W2942548206","https://openalex.org/W2031298554"],"abstract_inverted_index":{"The":[0],"epidermal":[1],"growth":[2],"factor":[3],"receptor":[4,23],"(EGFR)":[5],"is":[6],"commonly":[7],"expressed":[8],"in":[9,14,43,67,95,103,122],"colorectal":[10,71,101],"cancers":[11],"but":[12],"not":[13],"most":[15],"normal":[16],"tissues,":[17],"raising":[18],"the":[19,44,49,89,96],"possibility":[20],"that":[21,38],"this":[22,84,124],"could":[24],"serve":[25],"as":[26,114,116],"a":[27],"target":[28],"for":[29],"highly":[30],"selective":[31],"therapy.":[32],"Based":[33],"on":[34],"preclinical":[35],"studies":[36,60],"demonstrating":[37],"antagonists":[39],"of":[40,46,51,64,92,98],"EGFR":[41,65,93],"resulted":[42],"inhibition":[45],"tumor":[47],"growth,":[48],"development":[50],"clinical":[52,59,81],"reagents":[53],"has":[54],"been":[55],"aggressively":[56],"pursued.":[57],"Early":[58],"demonstrated":[61],"antitumor":[62],"activity":[63],"inhibitors":[66,94],"patients":[68,99],"with":[69,73,100],"advanced":[70],"cancer,":[72,102],"acceptable":[74],"toxicity.":[75],"This":[76],"early":[77],"success":[78],"fueled":[79],"rapid":[80],"development.":[82],"In":[83],"article,":[85],"we":[86,111,118],"will":[87],"review":[88],"current":[90],"status":[91],"treatment":[97],"an":[104],"effort":[105],"to":[106,120],"describe":[107],"both":[108],"how":[109],"far":[110],"have":[112],"come":[113],"well":[115],"where":[117],"need":[119],"go":[121],"optimizing":[123],"promising":[125],"therapeutic":[126],"approach.":[127]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}